Rate this article:

John Davis, BJUI Associate Editor: Urological Oncology






John Davis, BJUI Associate Editor for urological oncology, talks about why authors should submit to the BJUI.

The aim of the Journal is to publish high-quality papers with high-impact statements. Along with rapid reviews and publication, BJUI is supporting the impact of papers through social media, such as Twitter and Facebook. The journal will still be printed monthly, but additionally have an exciting web interface.

Please note that all submitted comments will be reviewed by the BJUI Web Team before they are considered for publishing on the site. Comments may take up to 48 hours to go live. If you have made a comment which has not appeared live after this time and you wish to discuss this matter further, please contact us.